Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children

Mediators of Inflammation

Volumn 2007, Issue , 2007, Pages

  Zorena, Katarzyna ^a   Myśliwska, Jolanta ^a   Myśliwiec, Małgorzata ^a   Balcerska, Anna ^a   Hak, Łukasz ^a   Lipowski, Paweł ^a   Raczyńska, Krystyna ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C PEPTIDE; C REACTIVE PROTEIN; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTAGONIST; UNCLASSIFIED DRUG; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; APPARATUS; ARTICLE; BLOOD PRESSURE MONITORING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OPHTHALMOLOGY; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; ALBUMINURIA; BLOOD; BLOOD PRESSURE; METABOLISM; PATHOLOGY; PREDICTION AND FORECASTING; STATISTICAL MODEL;

ADOLESCENT; ALBUMINURIA; BLOOD PRESSURE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-12; INTERLEUKIN-6; LOGISTIC MODELS; PREDICTIVE VALUE OF TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250836383     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2007/92196     Document Type: Article

References (26)

1. M. T. Schram N. Chaturvedi C. Schalkwijk Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 26 7 2003 2165 2173
2. F. Giorgino L. Laviola P. Cavallo Perin B. Solnica J. Fuller N. Chaturvedi Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 47 2004 6 1020 1028
3. H. Lund-Andersen Mechanisms for monitoring changes in retinal status following therapeutic intervention in diabetic retinopathy. Survey of Ophthalmology 47, supplement 2 2002 S270 S277
4. K. E. Schmid katharina.schmid@wienkav.at B. Neumaier-Ammerer U. Stolba S. Binder Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin ( HbA 1 c). Graefe's Archive for Clinical and Experimental Ophthalmology 244 11 2006 1446 1452
5. A. M. Abu el Asrar D. Maimone P. H. Morse S. Gregory A. T. Reder Cytokines in the vitreous of patients with proliferative diabetic retinopathy. American Journal of Ophthalmology 114 6 1992 731 736
6. S. Kojima T. Yamada M. Tamai Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases. Japanese Journal of Ophthalmology 45 1 2001 40 45
7. T. Yuuki r9210@fb3.so-net.ne.jp T. Kanda Y. Kimura Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. Journal of Diabetes and Its Complications 15 5 2001 257 259
8. S. Doganay C. Evereklioglu H. Er Comparison of serum NO, TNF-α, IL-1β, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16 2 2002 163 170
9. R. J. McCarter J. M. Hempe R. Gomez S. A. Chalew schale@lsuhsc.edu Biological variation in HbA 1 c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 27 6 2004 1259 1264
10. M. Yokoi S.-I. Yamagishi shoichi@med.kurume-u.ac.jp M. Takeuchi Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy. British Journal of Ophthalmology 89 6 2005 673 675
11. H. Sugimoto K. Shikata J. Wada S. Horiuchi H. Makino Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 42 7 1999 878 886
12. H. Rothe V. Burkart A. Faust H. Kolb Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia 39 1 1996 119 122
13. American Diabetes Association Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 7 1997 1183 1197
14. American Diabetes Association Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 11 2003 3160 3167
15. Early Treatment Diabetic Retinopathy Study Rerearch Group Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11. Ophthalmology 98, supplement 5 1991 807 822
16. Y. Dogan S. Akarsu B. Ustundag E. Yilmaz M. K. Gurgoze Serum IL-1β, IL-2, and IL-6 in insulin-dependent diabetic children. Mediators of Inflammation 2006 59206 2006 6 pages
17. H.-C. Lo S.-C. Lin Y.-M. Wang yumei@cch.org.tw The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus. Clinical Biochemistry 37 8 2004 666 672
18. M. Romano M. Pomilio S. Vigneri Endothelial perturbation in children and adolescents with type 1 diabetes. Diabetes Care 24 9 2001 1674 1678
19. R. Lorini M. de Amici G. d'Annunzio L. Vitali A. Scaramuzza Low serum levels of tumor necrosis factor-α in insulin-dependent diabetic children. Hormone Research 43 5 1995 206 209
20. M. Balasubramanyam mvdsc@vsnl.net M. Rema C. Premanand Biochemical and molecular mechanisms of diabetic retinopathy. Current Science 83 12 2002 1506 1514
21. P. E. Szmitko C.-H. Wang R. D. Weisel J. R. de Almeida T. J. Anderson S. Verma subodh.verma@sympatico.ca New markers of inflammation and endothelial cell activation - part I. Circulation 108 16 2003 1917 1923
22. B. Kulseng L. Vatten T. Espevik Soluble tumor necrosis factor receptors in sera from patients with insulin-dependent diabetes mellitus: relations to duration and complications of disease. Acta Diabetologica 36 1-2 1999 99 105
23. H. Funatsu tfunatsu@nifty.com H. Yamashita H. Noma T. Mimura T. Yamashita S. Hori Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. American Journal of Ophthalmology 133 1 2002 70 77
24. E. Shimizu H. Funatsu H. Yamashita T. Yamashita S. Hori Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema. Japanese Journal of Ophthalmology 46 1 2002 78 83
25. E. Głowacka M. Banasik P. Lewkowicz H. Tchórzewski The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro. Scandinavian Journal of Immunology 55 2 2002 210 217
26. G. Winkler O. Dworak F. Salamon D. Salamon G. Speer K. Cseh Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetologia 41 4 1998 488